FDA official logo
GSRS logoPFDA official logo

LEAD BAMZIREOTIDE NAVOXETAN PB-212

UNII:D2A42X3LCS
Type:INGREDIENT SUBSTANCE
Formula:C72H104N16O20S2.Pb
Preferred Substance Name:LEAD BAMZIREOTIDE NAVOXETAN PB-212
InChIKey:
GSRS Full Record:

  • 2941523-47-1
  • 2-[4-[2-[2-[2-[3-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-oxopropoxy]ethoxy]ethylamino]-2-oxoethyl]-10-(2-amino-2-oxoethyl)-7-(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lead-212(2+)
  • Lead (<sup>212</sup>Pb) Bamzireotide Navoxetan
  • Lead Bamzireotide Navoxetan Pb-212
  • Lead-<sup>212</sup>Pb, [N-[3-[2-[2-[[2-[7-[2-amino-2-(oxo-κO)ethyl]-4,10-bis[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN<sup>1</sup>,κN<sup>4</sup>,κN<sup>7</sup>,κN<sup>10</sup>]acetyl-κO]amino]ethoxy]ethoxy]-1-oxopropyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfidato(2-)]-
  • lead (<sup>212</sup>Pb) bamzireotide navoxetan [INN]



UNII - D2A42X3LCS | UNII Search Service